Robert J. Bitterman, President & CEO at Phio Pharmaceuticals Corp. (PHIO), bought 2,500 shares at $0.91 ($2K) on 2024-02-26, disclosed to the SEC on 2024-02-27.
Open-market purchase of $2k PHIO by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| PHIO | BUY | 2026-01-02 | $5K | — | Filing → |
| PHIO | BUY | 2025-12-29 | $5K | — | Filing → |
| PHIO | BUY | 2025-11-24 | $6K | — | Filing → |